{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:08:21Z","timestamp":1791216501836,"version":"4.1.0"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00210-023-02865-z","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T08:02:18Z","timestamp":1701158538000},"page":"3565-3584","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Old drug, new tricks: polymer-based nanoscale systems for effective cytarabine delivery"],"prefix":"10.1007","volume":"397","author":[{"given":"Nasrullah","family":"Jan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safiullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiza","family":"Nasar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asadullah","family":"Madni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Faisal","family":"Badshah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahsan","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad F.","family":"Bostanudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,28]]},"reference":[{"key":"2865_CR1","doi-asserted-by":"crossref","unstructured":"Abal\u0131, H, \u00dcr\u00fcn, Y, \u00d6ks\u00fczo\u011flu, B, Budako\u011flu, B, Y\u0131ld\u0131r\u0131m, N, G\u00fcler, T, . . . Zengin, N (2008) Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma. Cancer investigation, 26(4), 401\u2013406","DOI":"10.1080\/07357900701788098"},{"issue":"3","key":"2865_CR2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11051-023-05690-w","volume":"25","author":"R Abbasi","year":"2023","unstructured":"Abbasi R, Shineh G, Mobaraki M, Doughty S, Tayebi L (2023) Structural parameters of nanoparticles affecting their toxicity for biomedical applications: a review. J Nanopart Res 25(3):43","journal-title":"J Nanopart Res"},{"issue":"6","key":"2865_CR3","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jecm.2014.10.015","volume":"6","author":"G Ajnai","year":"2014","unstructured":"Ajnai G, Chiu A, Kan T, Cheng C-C, Tsai T-H, Chang J (2014) Trends of gold nanoparticle-based drug delivery system in cancer therapy. J Exp Clin Med 6(6):172\u2013178","journal-title":"J Exp Clin Med"},{"key":"2865_CR4","doi-asserted-by":"crossref","unstructured":"Akbarzadeh, A, Rezaei-Sadabady, R, Davaran, S, Joo, SW, Zarghami, N, Hanifehpour, Y, . . . Nejati-Koshki, K (2013) Liposome: classification, preparation, and applications. Nanoscale research letters, 8, 1\u20139","DOI":"10.1186\/1556-276X-8-102"},{"issue":"1","key":"2865_CR5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","volume":"65","author":"TM Allen","year":"2013","unstructured":"Allen TM, Cullis PR (2013) Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev 65(1):36\u201348","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"2865_CR6","doi-asserted-by":"publisher","first-page":"166746","DOI":"10.1016\/j.bbadis.2023.166746","volume":"166746","author":"Q Babar","year":"2023","unstructured":"Babar Q, Saeed A, Tabish TA, Sarwar M, Thorat ND (2023) Targeting the tumor microenvironment: potential strategy for cancer therapeutics. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 166746(6):166746. https:\/\/doi.org\/10.1016\/j.bbadis.2023.166746","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"key":"2865_CR7","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118931","volume":"267","author":"SF Badshah","year":"2021","unstructured":"Badshah SF, Akhtar N, Minhas MU, Khan KU, Khan S, Abdullah O, Naeem A (2021) Porous and highly responsive cross-linked \u03b2-cyclodextrin based nanomatrices for improvement in drug dissolution and absorption. Life Sci 267:118931","journal-title":"Life Sci"},{"key":"2865_CR8","doi-asserted-by":"crossref","unstructured":"Batool, N, Sarfraz, RM, Mahmood, A, Rehman, U, Zaman, M, Akbar, S, . . . Gad, HA (2023) Development and evaluation of cellulose derivative and pectin based swellable pH responsive hydrogel network for controlled delivery of cytarabine. Gels, 9(1), 60","DOI":"10.3390\/gels9010060"},{"key":"2865_CR9","doi-asserted-by":"crossref","unstructured":"Baumann, S, Huseynov, A, Goranova, D, Faust, M, Behnes, M, Nolte, F, . . . Akin, I (2014) Takotsubo cardiomyopathy after systemic consolidation therapy with high-dose intravenous cytarabine in a patient with acute myeloid leukemia. Oncol Res Treat, 37(9), 487\u2013490","DOI":"10.1159\/000365536"},{"key":"2865_CR10","doi-asserted-by":"crossref","unstructured":"Baumh\u00e4kel, M, Kasel, D, Rao-Schymanski, R, B\u00f6cker, R, Beckurts, K, Zaigler, M, . . . Fuhr, U (2001) Screening for inhibitory effects of antineoplastic agents on CYP3A4 in human liver microsomes. Int J Clin Pharmacol Ther, 39(12), 517\u2013528","DOI":"10.5414\/CPP39517"},{"key":"2865_CR11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejps.2015.12.031","volume":"83","author":"S Biswas","year":"2016","unstructured":"Biswas S, Kumari P, Lakhani PM, Ghosh B (2016) Recent advances in polymeric micelles for anti-cancer drug delivery. Eur J Pharm Sci 83:184\u2013202","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"2865_CR12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11060-004-3389-0","volume":"72","author":"F Bokstein","year":"2005","unstructured":"Bokstein F, Goor O, Shihman B, Rochkind S, Even-Sapir E, Metser U, Neufeld M (2005) Assessment of neurolymphomatosis by brachial plexus biopsy and PET\/CT. Report of a case. J Neuro-Oncol 72(2):163\u2013167","journal-title":"J Neuro-Oncol"},{"issue":"8","key":"2865_CR13","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.drudis.2017.05.015","volume":"22","author":"RJ Bose","year":"2017","unstructured":"Bose RJ, Ravikumar R, Karuppagounder V, Bennet D, Rangasamy S, Thandavarayan RA (2017) Lipid\u2013polymer hybrid nanoparticle-mediated therapeutics delivery: advances and challenges. Drug Discovery Today 22(8):1258\u20131265","journal-title":"Drug Discovery Today"},{"key":"2865_CR14","doi-asserted-by":"crossref","unstructured":"Byrd, JC, Ruppert, AS, Mr\u00f3zek, K, Carroll, AJ, Edwards, CG, Arthur, DC, . . . Moore, JO (2004) Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv (16)(p13q22) or t (16; 16)(p13; q22): results from CALGB 8461. J Clin Oncol, 22(6), 1087\u20131094","DOI":"10.1200\/JCO.2004.07.012"},{"issue":"26","key":"2865_CR15","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1039\/C4TB00171K","volume":"2","author":"A-M Caminade","year":"2014","unstructured":"Caminade A-M, Turrin C-O (2014) Dendrimers for drug delivery. J Mater Chem B 2(26):4055\u20134066","journal-title":"J Mater Chem B"},{"key":"2865_CR16","doi-asserted-by":"crossref","unstructured":"Chan, JM, Valencia, PM, Zhang, L, Langer, R, Farokhzad, OC (2010) Polymeric nanoparticles for drug delivery. Cancer Nanotechnol Meth Protocols, 163\u2013175","DOI":"10.1007\/978-1-60761-609-2_11"},{"issue":"6","key":"2865_CR17","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s42247-021-00335-x","volume":"5","author":"V Chandrakala","year":"2022","unstructured":"Chandrakala V, Aruna V, Angajala G (2022) Review on metal nanoparticles as nanocarriers: current challenges and perspectives in drug delivery systems. Emerg Mater 5(6):1593\u20131615","journal-title":"Emerg Mater"},{"key":"2865_CR18","doi-asserted-by":"crossref","unstructured":"Chaudhuri, A, Kumar, DN, Shaik, RA, Eid, BG, Abdel-Naim, A B, Md, S, . . . Agrawal, AK (2022) Lipid-based nanoparticles as a pivotal delivery approach in triple negative breast cancer (TNBC) therapy. Int J Mol Sci, 23(17), 10068","DOI":"10.3390\/ijms231710068"},{"issue":"2","key":"2865_CR19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.34172\/apb.2020.021","volume":"10","author":"I Chauhan","year":"2020","unstructured":"Chauhan I, Yasir M, Verma M, Singh AP (2020) Nanostructured lipid carriers: a groundbreaking approach for transdermal drug delivery. Adv Pharmaceut Bull 10(2):150","journal-title":"Adv Pharmaceut Bull"},{"issue":"12","key":"2865_CR20","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1517\/17425247.2010.527330","volume":"7","author":"BS Chhikara","year":"2010","unstructured":"Chhikara BS, Parang K (2010) Development of cytarabine prodrugs and delivery systems for leukemia treatment. Expert Opin Drug Deliv 7(12):1399\u20131414. https:\/\/doi.org\/10.1517\/17425247.2010.527330","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"2865_CR21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0268-960X(97)90005-9","volume":"11","author":"N Cole","year":"1997","unstructured":"Cole N, Gibson B (1997) High-dose cytosine arabinoside in the treatment of acute myeloid leukaemia. Blood Rev 11(1):39\u201345","journal-title":"Blood Rev"},{"key":"2865_CR22","doi-asserted-by":"crossref","unstructured":"Couvreur, P, Stella, B, Reddy, LH, Hillaireau, H, Dubernet, C, Desma\u00eble, D, . . . Clayette, P (2006) Squalenoyl nanomedicines as potential therapeutics. Nano Lett, 6(11), 2544\u20132548","DOI":"10.1021\/nl061942q"},{"issue":"10","key":"2865_CR23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/01.COT.0000534146.30839.ec","volume":"40","author":"ML Crain","year":"2018","unstructured":"Crain ML (2018) Daunorubicin & cytarabine liposome (vyxeos\u2122). Oncol Times 40(10):30","journal-title":"Oncol Times"},{"issue":"2","key":"2865_CR24","doi-asserted-by":"crossref","first-page":"513","DOI":"10.18596\/jotcsa.1190202","volume":"10","author":"I Dani\u015f","year":"2023","unstructured":"Dani\u015f I, G\u00f6lc\u00fc A, Duri\u015fehvar \u00dc (2023) Cytarabine determination from urine for toxicokinetic and excretion studies by high-performance liquid chromatography-tandem mass spectrometry. J Turk Chem Soc Sect Chem 10(2):513\u2013520","journal-title":"J Turk Chem Soc Sect Chem"},{"key":"2865_CR25","volume":"237","author":"PHC de Lima","year":"2021","unstructured":"de Lima PHC, Butera AP, Cabe\u00e7a LF, Ribeiro-Viana RM (2021) Liposome surface modification by phospholipid chemical reactions. Chem Phys Lipid 237:105084","journal-title":"Chem Phys Lipid"},{"issue":"12","key":"2865_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13205-018-1510-x","volume":"8","author":"G Deepa","year":"2018","unstructured":"Deepa G, Sivakumar K, Sajeevan T (2018) Molecular simulation and in vitro evaluation of chitosan nanoparticles as drug delivery systems for the controlled release of anticancer drug cytarabine against solid tumours. 3 Biotech 8(12):1\u201311. https:\/\/doi.org\/10.1007\/s13205-018-1510-x","journal-title":"3 Biotech"},{"key":"2865_CR27","doi-asserted-by":"crossref","unstructured":"Di Francia, R, Crisci, S, De Monaco, A, Cafiero, C, Re, A, Iaccarino, G, . . . Micera, A (2021) Response and toxicity to cytarabine therapy in leukemia and lymphoma: from dose puzzle to pharmacogenomic biomarkers. Cancers, 13(5), 966","DOI":"10.3390\/cancers13050966"},{"key":"2865_CR28","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.wneu.2019.05.123","volume":"128","author":"D Dornbos III","year":"2019","unstructured":"Dornbos D III, Elder JB, Otero JJ, Baiocchi RA, Slone HW, Puduvalli VK, Giglio P (2019) Spinal cord toxicity from intrathecal chemotherapy: a case with clinicopathologic correlation. World Neurosurg 128:381\u2013384","journal-title":"World Neurosurg"},{"key":"2865_CR29","doi-asserted-by":"crossref","unstructured":"Dos Santos, CA, Seckler, MM, Ingle, AP, Gupta, I, Galdiero, S, Galdiero, M, . . . Rai, M (2014) Silver nanoparticles: therapeutical uses, toxicity, and safety issues. J Pharm Sci, 103(7), 1931\u20131944","DOI":"10.1002\/jps.24001"},{"key":"2865_CR30","doi-asserted-by":"crossref","first-page":"153303382311520","DOI":"10.1177\/15330338231152083","volume":"22","author":"U Dristant","year":"2023","unstructured":"Dristant U, Mukherjee K, Saha S, Maity D (2023) An overview of polymeric nanoparticles-based drug delivery system in cancer treatment. Technol Cancer Res Treat 22:15330338231152084","journal-title":"Technol Cancer Res Treat"},{"key":"2865_CR31","doi-asserted-by":"crossref","unstructured":"Duan, Y, Dhar, A, Patel, C, Khimani, M, Neogi, S, Sharma, P, . . . Vekariya, RL (2020) A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems. RSC Adv, 10(45), 26777\u201326791","DOI":"10.1039\/D0RA03491F"},{"issue":"4","key":"2865_CR32","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41573-018-0005-0","volume":"18","author":"I Ekladious","year":"2019","unstructured":"Ekladious I, Colson YL, Grinstaff MW (2019) Polymer\u2013drug conjugate therapeutics: advances, insights and prospects. Nat Rev Drug Discovery 18(4):273\u2013294. https:\/\/doi.org\/10.1038\/s41573-018-0005-0","journal-title":"Nat Rev Drug Discovery"},{"issue":"7","key":"2865_CR33","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1039\/c2cs15327k","volume":"41","author":"M Elsabahy","year":"2012","unstructured":"Elsabahy M, Wooley KL (2012) Design of polymeric nanoparticles for biomedical delivery applications. Chem Soc Rev 41(7):2545\u20132561","journal-title":"Chem Soc Rev"},{"key":"2865_CR34","doi-asserted-by":"crossref","unstructured":"El-Subbagh HI, Al-Badr AA (2009) Cytarabine. Profiles of Drug Substances, Excipients and Related Methodology, vol. 34. Academic Press, pp. 37-113","DOI":"10.1016\/S1871-5125(09)34002-9"},{"issue":"47","key":"2865_CR35","doi-asserted-by":"crossref","first-page":"23000","DOI":"10.1039\/C9NR07391D","volume":"11","author":"Z Fang","year":"2019","unstructured":"Fang Z, Wang X, Sun Y, Fan R, Liu Z, Guo R, Xie D (2019) Sgc8 aptamer targeted glutathione-responsive nanoassemblies containing Ara-C prodrug for the treatment of acute lymphoblastic leukemia. Nanoscale 11(47):23000\u201323012","journal-title":"Nanoscale"},{"key":"2865_CR36","unstructured":"Faruqi A, Tadi P (2020) Cytarabine. StatPearls Publishing, Treasure Island (FL)"},{"key":"2865_CR37","unstructured":"Faruqi A, Tadi P (2022) Cytarabine. In xPharm: The Comprehensive Pharmacology Reference. Published online August, 12, 1-5"},{"issue":"3","key":"2865_CR38","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/btm2.10033","volume":"1","author":"Q Feng","year":"2016","unstructured":"Feng Q, Tong R (2016) Anticancer nanoparticulate polymer-drug conjugate. Bioeng Transl Med 1(3):277\u2013296","journal-title":"Bioeng Transl Med"},{"issue":"10","key":"2865_CR39","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1158\/1535-7163.MCT-08-0616","volume":"7","author":"CM Galmarini","year":"2008","unstructured":"Galmarini CM, Warren G, Kohli E, Zeman A, Mitin A, Vinogradov SV (2008) Polymeric nanogels containing the triphosphate form of cytotoxic nucleoside analogues show antitumor activity against breast and colorectal cancer cell lines. Mol Cancer Ther 7(10):3373\u20133380","journal-title":"Mol Cancer Ther"},{"issue":"10","key":"2865_CR40","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1021\/nl8017274","volume":"8","author":"D Gao","year":"2008","unstructured":"Gao D, Xu H, Philbert MA, Kopelman R (2008) Bioeliminable nanohydrogels for drug delivery. Nano Lett 8(10):3320\u20133324","journal-title":"Nano Lett"},{"key":"2865_CR41","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ijbiomac.2021.12.070","volume":"199","author":"D Geethakumari","year":"2022","unstructured":"Geethakumari D, Sathyabhama AB, Sathyan KR, Mohandas D, Somasekharan JV, Puthiyedathu ST (2022) Folate functionalized chitosan nanoparticles as targeted delivery systems for improved anticancer efficiency of cytarabine in MCF-7 human breast cancer cell lines. Int J Biol Macromol 199:150\u2013161. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.12.070","journal-title":"Int J Biol Macromol"},{"key":"2865_CR42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2021.02.016","volume":"332","author":"B Ghosh","year":"2021","unstructured":"Ghosh B, Biswas S (2021) Polymeric micelles in cancer therapy: state of the art. J Control Release 332:127\u2013147","journal-title":"J Control Release"},{"issue":"4","key":"2865_CR43","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3390\/nano11040964","volume":"11","author":"HI Gomes","year":"2021","unstructured":"Gomes HI, Martins CS, Prior JA (2021) Silver nanoparticles as carriers of anticancer drugs for efficient target treatment of cancer cells. Nanomaterials 11(4):964","journal-title":"Nanomaterials"},{"key":"2865_CR44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120571","volume":"601","author":"D Guimar\u00e3es","year":"2021","unstructured":"Guimar\u00e3es D, Cavaco-Paulo A, Nogueira E (2021) Design of liposomes as drug delivery system for therapeutic applications. Int J Pharm 601:120571","journal-title":"Int J Pharm"},{"issue":"7","key":"2865_CR45","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00210-022-02245-z","volume":"395","author":"S Hamimed","year":"2022","unstructured":"Hamimed S, Jabberi M, Chatti A (2022) Nanotechnology in drug and gene delivery. Naunyn Schmiedebergs Arch Pharmacol 395(7):769\u2013787","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2865_CR46","doi-asserted-by":"crossref","unstructured":"Hussain, Z, Rahim, MA, Jan, N, Shah, H, Rawas-Qalaji, M, Khan, S, . . . Sarfraz, RM (2021) Cell membrane cloaked nanomedicines for bio-imaging and immunotherapy of cancer: improved pharmacokinetics, cell internalization and anticancer efficacy. J Control Rel","DOI":"10.1016\/j.jconrel.2021.05.018"},{"issue":"40","key":"2865_CR47","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.2174\/1381612826999200820173253","volume":"26","author":"MA Jahangir","year":"2020","unstructured":"Jahangir MA, Taleuzzaman M, Kala C, Gilani SJ (2020) Advancements in polymer and lipid-based nanotherapeutics for cancer drug targeting. Curr Pharm Des 26(40):5119\u20135127","journal-title":"Curr Pharm Des"},{"key":"2865_CR48","doi-asserted-by":"publisher","unstructured":"Jan, N, Madni, A, Rahim, MA, Khan, NU, Jamshaid, T, Khan, A, . . . Shah, H (2021) In vitro anti-leukemic assessment and sustained release behaviour of cytarabine loaded biodegradable polymer based nanoparticles. Life Sci, 267, 118971. https:\/\/doi.org\/10.1016\/j.lfs.2020.118971","DOI":"10.1016\/j.lfs.2020.118971"},{"key":"2865_CR49","doi-asserted-by":"publisher","unstructured":"Jan, N, Madni, A, Khan, S, Shah, H, Akram, F, Khan, A, . . . Ashammakhi, N (2023) Biomimetic cell membrane\u2010coated poly (lactic\u2010co\u2010glycolic acid) nanoparticles for biomedical applications. Bioeng Transl Med, 8(2), e10441. https:\/\/doi.org\/10.1002\/btm2.10441","DOI":"10.1002\/btm2.10441"},{"key":"2865_CR50","doi-asserted-by":"crossref","unstructured":"Jan, N, Madni, A, Shah, H, Khan, S, Ijaz, QA, Badshah, SF, . . . Bostanudin, MF (2023) Development and statistical optimization of polymer-based nanoparticulate delivery system for enhancing cytarabine efficacy in leukemia treatment. J Pharmaceut Innov, 1\u201314","DOI":"10.1007\/s12247-023-09753-2"},{"issue":"4","key":"2865_CR51","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4333\/KPS.2008.38.4.255","volume":"38","author":"M-J Jin","year":"2008","unstructured":"Jin M-J, Hong J-H, Han H-K (2008) Synthesis and in-vitro evaluation of N4-amino acid derivatives of cytarabine for improving the oral delivery of cytarabine. J Pharm Investig 38(4):255\u2013259","journal-title":"J Pharm Investig"},{"issue":"6","key":"2865_CR52","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1177\/1078155215607090","volume":"22","author":"MA Jirasek","year":"2016","unstructured":"Jirasek MA, Herrington JD (2016) Cytarabine syndrome despite corticosteroid premedication in an adult undergoing induction treatment for acute myelogenous leukemia. J Oncol Pharm Pract 22(6):795\u2013800","journal-title":"J Oncol Pharm Pract"},{"key":"2865_CR53","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2165\/00003088-200039010-00002","volume":"39","author":"SA Johnson","year":"2000","unstructured":"Johnson SA (2000) Clinical pharmacokinetics of nucleoside analogues: focus on haematological malignancies. Clin Pharmacokinet 39:5\u201326","journal-title":"Clin Pharmacokinet"},{"key":"2865_CR54","first-page":"10","volume":"1","author":"NM Joseph","year":"2007","unstructured":"Joseph NM, Sharma PK (2007) Cross-linked nanoparticles of cytarabine: encapsulation, storage and in-vitro release. Afr J Pharm Pharmacol 1:10\u201313","journal-title":"Afr J Pharm Pharmacol"},{"issue":"11","key":"2865_CR55","doi-asserted-by":"crossref","first-page":"967","DOI":"10.4155\/tde-2017-0075","volume":"8","author":"E Kahraman","year":"2017","unstructured":"Kahraman E, G\u00fcng\u00f6r S, \u00d6zsoy Y (2017) Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery. Ther Deliv 8(11):967\u2013985","journal-title":"Ther Deliv"},{"key":"2865_CR56","first-page":"1","volume-title":"Hybrid nanomaterials for drug delivery","author":"H Kamali","year":"2022","unstructured":"Kamali H, Nosrati R, Malaekeh-Nikouei B (2022) Chapter 1 - nanostructures and their associated challenges for drug delivery. In: Kesharwani P, Jain NK (eds) Hybrid nanomaterials for drug delivery. Woodhead Publishing, pp 1\u201326"},{"key":"2865_CR57","doi-asserted-by":"crossref","unstructured":"Kantarjian, HM, O\u2019Brien, S, Smith, TL, Cortes, J, Giles, FJ, Beran, M, . . . Koller, C (2000) Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol, 18(3), 547\u2013547","DOI":"10.1200\/JCO.2000.18.3.547"},{"issue":"4","key":"2865_CR58","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/1061186X.2017.1380655","volume":"26","author":"U Kanwal","year":"2018","unstructured":"Kanwal U, Irfan Bukhari N, Ovais M, Abass N, Hussain K, Raza A (2018) Advances in nano-delivery systems for doxorubicin: an updated insight. J Drug Target 26(4):296\u2013310","journal-title":"J Drug Target"},{"issue":"1","key":"2865_CR59","doi-asserted-by":"crossref","first-page":"73","DOI":"10.12991\/mpj.2015198613","volume":"19","author":"G Karaku\u015f","year":"2015","unstructured":"Karaku\u015f G, Ya\u011flio\u011flu A\u015e, Zengi\u0307n H, Karaku\u015f N (2015) Synthesis, characterization and antiproliferative activities of novel modified poly (maleic anhydride-co-vinyl acetate)\/cytosine \u03b2-darabinofuranoside hydrochloride conjugate. Marmara Pharmaceut J 19(1):73\u201381","journal-title":"Marmara Pharmaceut J"},{"issue":"9","key":"2865_CR60","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.3390\/molecules22091445","volume":"22","author":"F-Y Kong","year":"2017","unstructured":"Kong F-Y, Zhang J-W, Li R-F, Wang Z-X, Wang W-J, Wang W (2017) Unique roles of gold nanoparticles in drug delivery, targeting and imaging applications. Molecules 22(9):1445","journal-title":"Molecules"},{"issue":"7","key":"2865_CR61","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/01.cad.0000171771.89682.f5","volume":"16","author":"P Kopterides","year":"2005","unstructured":"Kopterides P, Lignos M, Mentzelopoulos S, Armaganidis A, Pappa V (2005) Cytarabine-induced lung injury: case report. Anticancer Drugs 16(7):743\u2013745","journal-title":"Anticancer Drugs"},{"key":"2865_CR62","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00280-011-1800-z","volume":"69","author":"M Krogh-Madsen","year":"2012","unstructured":"Krogh-Madsen M, Bender B, Jensen MK, Nielsen OJ, Friberg LE, Honor\u00e9 PH (2012) Population pharmacokinetics of cytarabine, etoposide, and daunorubicin in the treatment for acute myeloid leukemia. Cancer Chemother Pharmacol 69:1155\u20131163","journal-title":"Cancer Chemother Pharmacol"},{"issue":"5","key":"2865_CR63","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.biotechadv.2012.10.002","volume":"31","author":"A Kumar","year":"2013","unstructured":"Kumar A, Zhang X, Liang X-J (2013) Gold nanoparticles: emerging paradigm for targeted drug delivery system. Biotechnol Adv 31(5):593\u2013606","journal-title":"Biotechnol Adv"},{"issue":"2","key":"2865_CR64","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0169-409X(96)00401-2","volume":"21","author":"GS Kwon","year":"1996","unstructured":"Kwon GS, Okano T (1996) Polymeric micelles as new drug carriers. Adv Drug Deliv Rev 21(2):107\u2013116","journal-title":"Adv Drug Deliv Rev"},{"key":"2865_CR65","doi-asserted-by":"crossref","unstructured":"Lancet, JE, Uy, GL, Cortes, JE, Newell, LF, Lin, TL, Ritchie, EK, . . . Solomon, SR (2018) CPX-351 (cytarabine and daunorubicin) liposome for injection versus conventional cytarabine plus daunorubicin in older patients with newly diagnosed secondary acute myeloid leukemia. J Clin Oncol, 36(26), 2684","DOI":"10.1200\/JCO.2017.77.6112"},{"issue":"8","key":"2865_CR66","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.addr.2007.11.009","volume":"60","author":"C Li","year":"2008","unstructured":"Li C, Wallace S (2008) Polymer-drug conjugates: recent development in clinical oncology. Adv Drug Deliv Rev 60(8):886\u2013898","journal-title":"Adv Drug Deliv Rev"},{"key":"2865_CR67","doi-asserted-by":"publisher","unstructured":"Liao, A-M, Zhang, Y, Hou, Y, Huang, J-H, Hui, M, Lee, K-K, . . . Chun, C (2021) Preparation, characterization, and cytotoxicity evaluation of self-assembled nanoparticles of diosgenin-cytarabine conjugate. Food Chem Toxicol, 151, 112101. https:\/\/doi.org\/10.1016\/j.fct.2021.112101","DOI":"10.1016\/j.fct.2021.112101"},{"issue":"2","key":"2865_CR68","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1523-5394.1999.07205.x","volume":"7","author":"C Lindley","year":"1999","unstructured":"Lindley C, McCune JS, Thomason TE, Lauder D, Sauls A, Adkins S, Sawyer WT (1999) Perception of chemotherapy side effects cancer versus noncancer patients. Cancer Pract 7(2):59\u201365","journal-title":"Cancer Pract"},{"key":"2865_CR69","doi-asserted-by":"crossref","unstructured":"Lindner, L, Ostermann, H, Hiddemann, W, Kiani, A, W\u00fcrfel, M, Illmer, T, . . . Schleyer, E (2008) AraU accumulation in patients with renal insufficiency as a potential mechanism for cytarabine neurotoxicity. Int J Hematol, 88(4), 381\u2013386","DOI":"10.1007\/s12185-008-0171-7"},{"issue":"1\u20132","key":"2865_CR70","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.ijpharm.2014.07.032","volume":"473","author":"J Liu","year":"2014","unstructured":"Liu J, Jiang Y, Cui Y, Xu C, Ji X, Luan Y (2014) Cytarabine-AOT catanionic vesicle-loaded biodegradable thermosensitive hydrogel as an efficient cytarabine delivery system. Int J Pharm 473(1\u20132):560\u2013571. https:\/\/doi.org\/10.1016\/j.ijpharm.2014.07.032","journal-title":"Int J Pharm"},{"issue":"42","key":"2865_CR71","doi-asserted-by":"crossref","first-page":"35991","DOI":"10.1039\/C6RA02051H","volume":"6","author":"J Liu","year":"2016","unstructured":"Liu J, Zhao D, Ma N, Luan Y (2016) Highly enhanced leukemia therapy and oral bioavailability from a novel amphiphilic prodrug of cytarabine. RSC Adv 6(42):35991\u201335999","journal-title":"RSC Adv"},{"key":"2865_CR72","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jcis.2016.10.041","volume":"487","author":"J Liu","year":"2017","unstructured":"Liu J, Zhao D, He W, Zhang H, Li Z, Luan Y (2017) Nanoassemblies from amphiphilic cytarabine prodrug for leukemia targeted therapy. J Colloid Interface Sci 487:239\u2013249","journal-title":"J Colloid Interface Sci"},{"key":"2865_CR73","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.molliq.2017.12.086","volume":"251","author":"R Liu","year":"2018","unstructured":"Liu R, Zhang J, Zhang D, Wang K, Luan Y (2018) Self-assembling nanoparticles based on cytarabine prodrug for enhanced leukemia treatment. J Mol Liq 251:178\u2013184","journal-title":"J Mol Liq"},{"issue":"11","key":"2865_CR74","volume":"25","author":"L Liu","year":"2021","unstructured":"Liu L, Xu Z, Liu Y, Yin Z-Z, Sheng Y, Ding C, Kong Y (2021) Facile synthesis of calcium carbonate\/polyacrylic acid hydrogels for pH-responsive delivery of cytarabine. J Saudi Chem Soc 25(11):101344","journal-title":"J Saudi Chem Soc"},{"issue":"4","key":"2865_CR75","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3390\/molecules27041372","volume":"27","author":"P Liu","year":"2022","unstructured":"Liu P, Chen G, Zhang J (2022) A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives. Molecules 27(4):1372","journal-title":"Molecules"},{"key":"2865_CR76","doi-asserted-by":"crossref","unstructured":"Liu, Q, Wang, H, Li, G, Liu, M, Ding, J, Huang, X, . . . Huayue, W (2019) A photocleavable low molecular weight hydrogel for light-triggered drug delivery. Chin Chem Lett, 30(2), 485\u2013488","DOI":"10.1016\/j.cclet.2018.06.009"},{"key":"2865_CR77","volume":"8","author":"R Ma","year":"2021","unstructured":"Ma R, Shi L (2021) Trade-off effect of polymeric nano-medicine in anti-cancer drug delivery. Giant 8:100074","journal-title":"Giant"},{"issue":"1","key":"2865_CR78","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12951-022-01309-9","volume":"20","author":"K Mahmoud","year":"2022","unstructured":"Mahmoud K, Swidan S, El-Nabarawi M, Teaima M (2022) Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances. J Nanobiotechnol 20(1):109","journal-title":"J Nanobiotechnol"},{"issue":"4","key":"2865_CR79","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.nano.2012.11.010","volume":"9","author":"B Mandal","year":"2013","unstructured":"Mandal B, Bhattacharjee H, Mittal N, Sah H, Balabathula P, Thoma LA, Wood GC (2013) Core\u2013shell-type lipid\u2013polymer hybrid nanoparticles as a drug delivery platform. Nanomed Nanotechnol Biol Med 9(4):474\u2013491","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"12","key":"2865_CR80","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1039\/b611123h","volume":"36","author":"M Marcos","year":"2007","unstructured":"Marcos M, Martin-Rapun R, Omenat A, Serrano JL (2007) Highly congested liquid crystal structures: dendrimers, dendrons, dendronized and hyperbranched polymers. Chem Soc Rev 36(12):1889\u20131901","journal-title":"Chem Soc Rev"},{"key":"2865_CR81","first-page":"20","volume":"1257","author":"K Metzeler","year":"2009","unstructured":"Metzeler K (2009) Cytarabine\/mitoxantrone idiopathic hyperammonaemia leading to coma. Reactions 1257:20","journal-title":"Reactions"},{"issue":"10","key":"2865_CR82","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.3390\/molecules23102527","volume":"23","author":"Z Mhlwatika","year":"2018","unstructured":"Mhlwatika Z, Aderibigbe BA (2018) Polymeric nanocarriers for the delivery of antimalarials. Molecules 23(10):2527","journal-title":"Molecules"},{"issue":"8","key":"2865_CR83","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.3390\/pharmaceutics14081722","volume":"14","author":"RDA Miguel","year":"2022","unstructured":"Miguel RDA, Hirata AS, Jimenez PC, Lopes LB, Costa-Lotufo LV (2022) Beyond formulation: contributions of nanotechnology for translation of anticancer natural products into new drugs. Pharmaceutics 14(8):1722","journal-title":"Pharmaceutics"},{"issue":"1","key":"2865_CR84","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1039\/B901839P","volume":"40","author":"MA Mintzer","year":"2011","unstructured":"Mintzer MA, Grinstaff MW (2011) Biomedical applications of dendrimers: a tutorial. Chem Soc Rev 40(1):173\u2013190","journal-title":"Chem Soc Rev"},{"key":"2865_CR85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2162-3619-2-20","volume":"2","author":"RL Momparler","year":"2013","unstructured":"Momparler RL (2013) Optimization of cytarabine (ARA-C) therapy for acute myeloid leukemia. Exp Hematol Oncol 2:1\u20135","journal-title":"Exp Hematol Oncol"},{"key":"2865_CR86","doi-asserted-by":"crossref","unstructured":"Mori, T, Yamazaki, R, Nakazato, T, Aisa, Y, Enoki, S, Arai, M, . . . Okamoto, S (2006) Excretion of cytosine arabinoside in saliva after its administration at high doses. Anti-cancer Drugs, 17(5), 597\u2013598","DOI":"10.1097\/00001813-200606000-00015"},{"key":"2865_CR87","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.2147\/IJN.S198353","volume":"14","author":"A Mukherjee","year":"2019","unstructured":"Mukherjee A, Waters AK, Kalyan P, Achrol AS, Kesari S, Yenugonda VM (2019) Lipid\u2013polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives. Int J Nanomed 14:1937\u20131952. https:\/\/doi.org\/10.2147\/IJN.S198353","journal-title":"Int J Nanomed"},{"issue":"1","key":"2865_CR88","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/03639040802178144","volume":"35","author":"R Mulik","year":"2009","unstructured":"Mulik R, Kulkarni V, Murthy R (2009) Chitosan-based thermosensitive hydrogel containing liposomes for sustained delivery of cytarabine. Drug Dev Ind Pharm 35(1):49\u201356. https:\/\/doi.org\/10.1080\/03639040802178144","journal-title":"Drug Dev Ind Pharm"},{"issue":"6","key":"2865_CR89","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.addr.2007.04.012","volume":"59","author":"R M\u00fcller","year":"2007","unstructured":"M\u00fcller R, Petersen R, Hommoss A, Pardeike J (2007) Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev 59(6):522\u2013530","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"2865_CR90","doi-asserted-by":"crossref","first-page":"305","DOI":"10.15171\/apb.2015.043","volume":"5","author":"N Naseri","year":"2015","unstructured":"Naseri N, Valizadeh H, Zakeri-Milani P (2015) Solid lipid nanoparticles and nanostructured lipid carriers: structure, preparation and application. Adv Pharmaceut Bull 5(3):305","journal-title":"Adv Pharmaceut Bull"},{"issue":"4","key":"2865_CR91","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/03602559.2014.958780","volume":"54","author":"A Nasir","year":"2015","unstructured":"Nasir A, Kausar A, Younus A (2015) A review on preparation, properties and applications of polymeric nanoparticle-based materials. Polym-Plast Technol Eng 54(4):325\u2013341. https:\/\/doi.org\/10.1080\/03602559.2014.958780","journal-title":"Polym-Plast Technol Eng"},{"key":"2865_CR92","doi-asserted-by":"crossref","unstructured":"Nurgali K, Jagoe RT, Abalo R (2018) Adverse effects of cancer chemotherapy: Anything new to improve tolerance and reduce sequelae?. Front Pharmacol 9:245","DOI":"10.3389\/fphar.2018.00245"},{"issue":"3","key":"2865_CR93","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/13543776.2020.1720649","volume":"30","author":"R Paliwal","year":"2020","unstructured":"Paliwal R, Paliwal SR, Kenwat R, Kurmi BD, Sahu MK (2020) Solid lipid nanoparticles: a review on recent perspectives and patents. Expert Opin Ther Pat 30(3):179\u2013194","journal-title":"Expert Opin Ther Pat"},{"key":"2865_CR94","doi-asserted-by":"crossref","unstructured":"Parodi, A, Kolesova, EP, Voronina, MV, Frolova, AS, Kostyushev, D, Trushina, DB, . . . Zamyatnin Jr, AA (2022) Anticancer nanotherapeutics in clinical trials: the work behind clinical translation of nanomedicine. Int J Mol Sci, 23(21), 13368","DOI":"10.3390\/ijms232113368"},{"key":"2865_CR95","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1155\/2017\/5175629","volume":"1","author":"J Parrott","year":"2017","unstructured":"Parrott J, Holland M (2017) Undetected severe fetal myelosuppression following administration of high-dose cytarabine for acute myeloid leukemia: is more frequent surveillance necessary? Case Rep Obstet Gynecol 1:5. https:\/\/doi.org\/10.1155\/2017\/5175629","journal-title":"Case Rep Obstet Gynecol"},{"issue":"8\u20139","key":"2865_CR96","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.progpolymsci.2007.05.008","volume":"32","author":"G Pasut","year":"2007","unstructured":"Pasut G, Veronese F (2007) Polymer\u2013drug conjugation, recent achievements and general strategies. Prog Polym Sci 32(8\u20139):933\u2013961","journal-title":"Prog Polym Sci"},{"key":"2865_CR97","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11060-006-9218-x","volume":"81","author":"S Phuphanich","year":"2007","unstructured":"Phuphanich S, Maria B, Braeckman R, Chamberlain M (2007) A pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepoCyt\u00ae) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III study. J Neurooncol 81:201\u2013208","journal-title":"J Neurooncol"},{"issue":"2","key":"2865_CR98","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.33549\/physiolres.933424","volume":"65","author":"R Pola","year":"2016","unstructured":"Pola R, Janou\u0161kov\u00e1 O, Etrych T (2016) The pH-dependent and enzymatic release of cytarabine from hydrophilic polymer conjugates. Physiol Res 65(2):S225\u2013S232","journal-title":"Physiol Res"},{"key":"2865_CR99","doi-asserted-by":"crossref","unstructured":"Pourmadadi, M, Eshaghi, MM, Ostovar, S, Mohammadi, Z, Sharma, RK, Paiva-Santos, AC, . . . Pandey, S (2023) Innovative nanomaterials for cancer diagnosis, imaging, and therapy: drug delivery applications. J Drug Deliv Sci Technol, 104357","DOI":"10.1016\/j.jddst.2023.104357"},{"issue":"36","key":"2865_CR100","doi-asserted-by":"crossref","first-page":"22057","DOI":"10.1039\/D1RA03770F","volume":"11","author":"P Prasanthan","year":"2021","unstructured":"Prasanthan P, Kishore N (2021) Self-assemblies of pluronic micelles in partitioning of anticancer drugs and effectiveness of this system towards target protein. RSC Adv 11(36):22057\u201322069","journal-title":"RSC Adv"},{"issue":"2","key":"2865_CR101","doi-asserted-by":"publisher","first-page":"e1764","DOI":"10.1002\/cnr2.1764","volume":"6","author":"A Pulumati","year":"2023","unstructured":"Pulumati A, Pulumati A, Dwarakanath BS, Verma A, Papineni RV (2023) Technological advancements in cancer diagnostics: improvements and limitations. Cancer Rep 6(2):e1764. https:\/\/doi.org\/10.1002\/cnr2.1764","journal-title":"Cancer Rep"},{"issue":"58","key":"2865_CR102","doi-asserted-by":"publisher","first-page":"53578","DOI":"10.1039\/C6RA10111A","volume":"6","author":"R Raj","year":"2016","unstructured":"Raj R, Raj PM, Ram A (2016) Preparation and characterization of solid lipid nanoparticles loaded with cytarabine via a micellar composition for leukemia. RSC Adv 6(58):53578\u201353586. https:\/\/doi.org\/10.1039\/C6RA10111A","journal-title":"RSC Adv"},{"issue":"5","key":"2865_CR103","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1021\/acs.molpharmaceut.0c01243","volume":"18","author":"P Rajagopal","year":"2021","unstructured":"Rajagopal P, Jayandharan GR, Krishnan UM (2021) Evaluation of the anticancer activity of pH-sensitive polyketal nanoparticles for acute myeloid leukemia. Mol Pharm 18(5):2015\u20132031. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c01243","journal-title":"Mol Pharm"},{"key":"2865_CR104","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.clinthera.2009.11.017","volume":"31","author":"T Robak","year":"2009","unstructured":"Robak T, Wierzbowska A (2009) Current and emerging therapies for acute myeloid leukemia. Clin Ther 31:2349\u20132370","journal-title":"Clin Ther"},{"key":"2865_CR105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.chemphyslip.2014.03.006","volume":"181","author":"E Rostami","year":"2014","unstructured":"Rostami E, Kashanian S, Azandaryani AH, Faramarzi H, Dolatabadi JEN, Omidfar K (2014) Drug targeting using solid lipid nanoparticles. Chem Phys Lipid 181:56\u201361","journal-title":"Chem Phys Lipid"},{"issue":"1","key":"2865_CR106","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1166\/jbn.2007.016","volume":"3","author":"K Ruckmani","year":"2007","unstructured":"Ruckmani K, Sivakumar M, Kumar SS (2007) Nanoparticular drug delivery system of cytarabine hydrochloride (CTH) for improved treatment of lymphoma. J Biomed Nanotechnol 3(1):90\u201396. https:\/\/doi.org\/10.1166\/jbn.2007.016","journal-title":"J Biomed Nanotechnol"},{"key":"2865_CR107","doi-asserted-by":"crossref","unstructured":"Salvi, L, Dubey, CK, Sharma, K, Nagar, D, Meghani, M, Goyal, S, . . . Sharma, A (2020) A synthesis, properties and application as a possible drug delivery systems dendrimers\u2013a review. Asian J Pharmaceut Res Develop, 8(2), 107\u2013113","DOI":"10.22270\/ajprd.v8i2.676"},{"issue":"5","key":"2865_CR108","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1517\/17425255.2015.985648","volume":"11","author":"C Serdjebi","year":"2015","unstructured":"Serdjebi C, Milano G, Ciccolini J (2015) Role of cytidine deaminase in toxicity and efficacy of nucleosidic analogs. Expert Opin Drug Metab Toxicol 11(5):665\u2013672","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"2865_CR109","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA: A cancer J Clin 73(1):17\u201348. https:\/\/doi.org\/10.3322\/caac.21763","journal-title":"CA: A cancer J Clin"},{"key":"2865_CR110","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2020.102317","volume":"286","author":"TA Singh","year":"2020","unstructured":"Singh TA, Das J, Sil PC (2020) Zinc oxide nanoparticles: a comprehensive review on its synthesis, anticancer and drug delivery applications as well as health risks. Adv Coll Interface Sci 286:102317","journal-title":"Adv Coll Interface Sci"},{"issue":"11","key":"2865_CR111","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4155\/tde-2019-0010","volume":"10","author":"M Suhail","year":"2019","unstructured":"Suhail M, Rosenholm JM, Minhas MU, Badshah SF, Naeem A, Khan KU, Fahad M (2019) Nanogels as drug-delivery systems: a comprehensive overview. Ther Deliv 10(11):697\u2013717","journal-title":"Ther Deliv"},{"key":"2865_CR112","unstructured":"Suzuki, K, Nakazato, T, Sanada, Y, Mihara, A, Tachikawa, N, Kurai, H, . . . Kakimoto, T (2010) Successful treatment with hyper-CVAD and highly active anti-retroviral therapy (HAART) for AIDS-related Burkitt lymphoma. [Rinsho Ketsueki] The Japan J Clin Hematol, 51(3), 207\u2013212"},{"issue":"1\u20132","key":"2865_CR113","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ijpharm.2016.09.063","volume":"513","author":"A Szulc","year":"2016","unstructured":"Szulc A, Pulaski L, Appelhans D, Voit B, Klajnert-Maculewicz B (2016) Sugar-modified poly (propylene imine) dendrimers as drug delivery agents for cytarabine to overcome drug resistance. Int J Pharm 513(1\u20132):572\u2013583","journal-title":"Int J Pharm"},{"key":"2865_CR114","doi-asserted-by":"crossref","unstructured":"Tahir, N, Haseeb, MT, Madni, A, Parveen, F, Khan, MM, Khan, S, . . . Khan, A (2019) Lipid polymer hybrid nanoparticles: a novel approach for drug delivery. Role Novel Drug Deliv Vehicles Nanobiomed, 59","DOI":"10.5772\/intechopen.88269"},{"issue":"4","key":"2865_CR115","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3109\/10717544.2015.1092183","volume":"23","author":"SV Talluri","year":"2016","unstructured":"Talluri SV, Kuppusamy G, Karri VVSR, Tummala S, Madhunapantula SV (2016) Lipid-based nanocarriers for breast cancer treatment\u2013comprehensive review. Drug Delivery 23(4):1291\u20131305","journal-title":"Drug Delivery"},{"issue":"1","key":"2865_CR116","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/17425247.2019.1554647","volume":"16","author":"T Vangijzegem","year":"2019","unstructured":"Vangijzegem T, Stanicki D, Laurent S (2019) Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics. Expert Opin Drug Deliv 16(1):69\u201378","journal-title":"Expert Opin Drug Deliv"},{"key":"2865_CR117","doi-asserted-by":"publisher","unstructured":"Vardanyan, R, Hruby, V (2006) Synthesis of essential drugs: Elsevier. https:\/\/doi.org\/10.1016\/B978-044452166-8\/50036-4","DOI":"10.1016\/B978-044452166-8\/50036-4"},{"key":"2865_CR118","doi-asserted-by":"publisher","unstructured":"Vijayan, V, Uthaman, S, Park, I-K (2018) Cell membrane coated nanoparticles: an emerging biomimetic nanoplatform for targeted bioimaging and therapy. Biomim Med Mater, 45\u201359. https:\/\/doi.org\/10.1007\/978-981-13-0445-3_3","DOI":"10.1007\/978-981-13-0445-3_3"},{"issue":"1","key":"2865_CR119","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijpharm.2013.08.079","volume":"457","author":"M Wacker","year":"2013","unstructured":"Wacker M (2013) Nanocarriers for intravenous injection\u2014the long hard road to the market. Int J Pharm 457(1):50\u201362","journal-title":"Int J Pharm"},{"issue":"7","key":"2865_CR120","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1039\/c3bm60027k","volume":"1","author":"J Wang","year":"2013","unstructured":"Wang J, Yin C, Tang G, Lin X, Wu Q (2013) Synthesis, characterization, and in vitro evaluation of two synergistic anticancer drug-containing hepatoma-targeting micelles formed from amphiphilic random copolymer. Biomater Sci 1(7):774\u2013782","journal-title":"Biomater Sci"},{"key":"2865_CR121","volume":"81","author":"K Wr\u00f3bel","year":"2023","unstructured":"Wr\u00f3bel K, Der\u0119gowska A, Betlej G, Walczak M, Wnuk M, Lewi\u0144ska A, Wo\u0142owiec S (2023) Cytarabine and dexamethasone-PAMAM dendrimer di-conjugate sensitizes human acute myeloid leukemia cells to apoptotic cell death. J Drug Deliv Sci Technol 81:104242","journal-title":"J Drug Deliv Sci Technol"},{"issue":"9","key":"2865_CR122","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.7150\/thno.15464","volume":"6","author":"H Xing","year":"2016","unstructured":"Xing H, Hwang K, Lu Y (2016) Recent developments of liposomes as nanocarriers for theranostic applications. Theranostics 6(9):1336","journal-title":"Theranostics"},{"issue":"3","key":"2865_CR123","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1208\/s12249-010-9519-4","volume":"11","author":"KS Yadav","year":"2010","unstructured":"Yadav KS, Sawant KK (2010) Modified nanoprecipitation method for preparation of cytarabine-loaded PLGA nanoparticles. AAPS PharmSciTech 11(3):1456\u20131465. https:\/\/doi.org\/10.1208\/s12249-010-9519-4","journal-title":"AAPS PharmSciTech"},{"issue":"8","key":"2865_CR124","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3109\/02652048.2011.615949","volume":"28","author":"KS Yadav","year":"2011","unstructured":"Yadav KS, Jacob S, Sachdeva G, Chuttani K, Mishra AK, Sawant KK (2011) Long circulating PEGylated PLGA nanoparticles of cytarabine for targeting leukemia. J Microencapsul 28(8):729\u2013742","journal-title":"J Microencapsul"},{"issue":"39","key":"2865_CR125","doi-asserted-by":"crossref","first-page":"2002655","DOI":"10.1002\/adfm.202002655","volume":"30","author":"M Ye","year":"2020","unstructured":"Ye M, Zhao Y, Wang Y, Yodsanit N, Xie R, Gong S (2020) pH-responsive polymer\u2013drug conjugate: an effective strategy to combat the antimicrobial resistance. Adv Func Mater 30(39):2002655","journal-title":"Adv Func Mater"},{"issue":"1","key":"2865_CR126","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcis.2010.05.028","volume":"349","author":"C Yin","year":"2010","unstructured":"Yin C, Li X, Wu Q, Wang J-L, Lin X-F (2010) Multidrug nanoparticles based on novel random copolymer containing cytarabine and fluorodeoxyuridine. J Colloid Interface Sci 349(1):153\u2013158","journal-title":"J Colloid Interface Sci"},{"key":"2865_CR127","doi-asserted-by":"publisher","unstructured":"Yoon, JH, Yoon, JY, Park, HJ, Son, MH, Kim, SH, Kim, W, . . . Park, B K (2014) Diffuse cerebral vasospasm with infarct after intrathecal cytarabine in childhood leukemia. Pediatr Int, 56(6), 921\u2013924. https:\/\/doi.org\/10.1111\/ped.12394","DOI":"10.1111\/ped.12394"},{"key":"2865_CR128","doi-asserted-by":"crossref","unstructured":"Zeng, L, Gowda, B, Ahmed, MG, Abourehab, MA, Chen, Z-S, Zhang, C, . . . Kesharwani, P (2023) Advancements in nanoparticle-based treatment approaches for skin cancer therapy. Mol Cancer, 22(1), 1\u201350","DOI":"10.1186\/s12943-022-01708-4"},{"issue":"1","key":"2865_CR129","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/mabi.201500193","volume":"16","author":"R Zhang","year":"2016","unstructured":"Zhang R, Yang J, Zhou Y, Shami PJ, Kope\u010dek J (2016) N-(2-hydroxypropyl) methacrylamide copolymer\u2013drug conjugates for combination chemotherapy of acute myeloid leukemia. Macromol Biosci 16(1):121\u2013128","journal-title":"Macromol Biosci"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02865-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-023-02865-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02865-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T08:09:12Z","timestamp":1716365352000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-023-02865-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,28]]},"references-count":129,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["2865"],"URL":"https:\/\/doi.org\/10.1007\/s00210-023-02865-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,28]]},"assertion":[{"value":"31 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no competing interests or personal relationships that have influence on the work reported in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"During the preparation of this work, we used ChatGPT to improve the readability and language of the work. After using this tool, we reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}}]}}